Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Resident doctors had more facial skin discoloration than medical students during COVID-19.

Monocytes might be linked to hair loss after COVID-19.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

The pandemic changed how often certain skin conditions were diagnosed.

FMH foods may help manage post-acute COVID-19 symptoms safely and easily.

Many dermatology patients experienced anxiety, depression, PTSD, and skin issues after the February 6, 2023 earthquakes, highlighting the need for combined skin and mental health care.

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

COVID-19 infection may cause hair loss a few months after recovery.

Stress and COVID-19 can worsen hair loss conditions like alopecia areata.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Post-COVID-19 patients are at risk for hair loss.

Hair loss can happen after both mild and severe COVID-19, and areas with more COVID-19 cases may see more hair loss cases.

The study suggests pandemic stress might worsen or trigger hair loss problems.

COVID-19 can cause hair loss and nail issues, with treatments available for these conditions.

COVID-19 vaccines caused mostly mild side effects in Bangladeshi medical students, with fewer issues after more doses.

People who had severe COVID-19 are more likely to experience hair loss.

The COVID-19 pandemic has increased hair loss and psychological distress in women.

Migrant and minority communities face higher rates of alopecia due to genetic, environmental, and cultural factors, needing better healthcare access and culturally aware treatments.

Long COVID causes various long-term health issues and needs better awareness and treatment.

COVID-19-related hair loss may be linked to blood flow disorders and inflammation.

COVID-19 can cause various skin issues, from mild rashes to severe conditions.

COVID-19 mRNA vaccines may increase the risk of flare-ups in certain inflammatory diseases.